
1. j pathol. 2011 jan;178(1):212-21. doi: 10.1016/j.ajpath.2010.11.008. epub 2010
dec 23.

protein kinase c-theta required development experimental cerebral
malaria.

fauconnier m(1), bourigault ml, meme s, szeremeta f, palomo j, danneels a,
charron s, fick l, jacobs m, beloeil jc, ryffel b, quesniaux vf.

author information: 
(1)university orléans cnrs, molecular immunology embryology umr6218,
orléans, france.

cerebral malaria severe neurologic complication children young
adults infected plasmodium falciparum. t-cell activation required for
development plasmodium berghei anka (pba)-induced experimental cerebral
malaria (cm). characterize t-cell activation pathway involved, role of
protein kinase c-theta (pkc-θ) experimental cm development examined.
pkc-θ-deficient mice resistant cm development. absence pkc-θ, no
neurologic sign cm developed blood stage pba infection. resistance of
pkc-θ-deficient mice correlated unaltered cerebral microcirculation and
absence ischemia, documented magnetic resonance imaging magnetic
resonance angiography, whereas wild-type mice developed distinct microvascular
pathology. recruitment activation cd8(+) cells, icam-1 cd69
expression reduced brain resistant mice; however, pulmonary
inflammation edema associated pba infection still present the
absence functional pkc-θ. resistant pkc-θ-deficient mice developed high
parasitemia, died 3 weeks severe anemia. therefore, pkc-θ signaling
is crucial recruitment cd8(+) cells development brain
microvascular pathology resulting fatal experimental cm, may represent a
novel therapeutic target cm.

copyright â© 2011 american society investigative pathology. published by
elsevier inc. rights reserved.

doi: 10.1016/j.ajpath.2010.11.008 
pmcid: pmc3069819
pmid: 21224058  [indexed medline]

